IQ Capital

Activity from announced rounds

Activity in this selectionOct 11, 2026 · Europe · Jan 1, 2026
Rounds participated in
8
Confirmed lead rounds
0
7 roles undisclosed
New companies
8
First participation on record · 0 follow-on
Funding in participating rounds
$265.9M
8 disclosed · full round size, not this investor’s share

By stage

Series A4
Undisclosed2
Seed1
Series C+1

By primary sector

Biotech2
Climate tech2
Cybersecurity2
Hardware1
Industrial tech1

By country

United Kingdom7
Germany1

Rounds

8 in this selection
Mindgard

Mindgard helps enterprise security teams find and address vulnerabilities in AI models, applications and agents.

$30MSeries A
Participant
QuantumDiamonds

Develops technology to test and find defects in semiconductor products

€15MUndisclosed
Role not disclosed
IMU Biosciences

Profiles human immune systems using multi-omic analysis and machine learning for disease research.

$53MSeries A
Role not disclosed
RevEng.AI

Provides binary-level AI analysis of compiled software to detect hidden vulnerabilities and supply chain threats

$15MSeries A
Role not disclosed
Imperagen

Uses quantum physics simulation and AI to engineer high-performance enzymes for pharma and industrial markets

£5MSeed
Role not disclosed
Nyobolt

Develops ultra-fast-charging battery systems for autonomous robots, physical AI applications, and AI data center power infrastructure

$60MSeries C
Role not disclosed
Rivan

Develops synthetic fuel infrastructure for domestic energy production

$34MUndisclosed
Role not disclosed
Isembard

Develops software to automate manufacturing of key component parts for industries

$50MSeries A
Role not disclosed